CCM
ABMD

Coe Capital Management’s Abiomed Inc ABMD Stock Holding History

Coe Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$807K Buy
2,587
+23
+0.9% +$7.06K 0.76% 38
2021
Q1 		$817K Sell
2,564
-68
-3% -$21.8K 0.82% 36
2020
Q4 		$853K Sell
2,632
-11
-0.4% -$3.04K 0.93% 34
2020
Q3 		$732K Sell
2,643
-136
-5% -$39.2K 0.98% 32
2020
Q2 		$671K Sell
2,779
-60
-2% -$12K 1% 35
2020
Q1 		$412K Buy
2,839
+209
+8% +$34.7K 0.69% 45
2019
Q4 		$449K Sell
2,630
-682
-21% -$126K 0.57% 58
2019
Q3 		$589K Buy
3,312
+105
+3% +$22.7K 0.65% 58
2019
Q2 		$835K Buy
3,207
+290
+10% +$76.9K 0.92% 39
2019
Q1 		$833K Sell
2,917
-34
-1% -$11.3K 0.97% 37
2018
Q4 		$959K Sell
2,951
-588
-17% -$204K 1.18% 27
2018
Q3 		$1.59M Buy
3,539
+95
+3% +$37.4K 1.57% 26
2018
Q2 		$1.41M Sell
3,444
-1,101
-24% -$399K 1.57% 28
2018
Q1 		$1.32M Sell
4,545
-1,405
-24% -$356K 1.43% 29
2017
Q4 		$1.11M Sell
5,950
-160
-3% -$29.9K 1.18% 34
2017
Q3 		$1.03M Sell
6,110
-480
-7% -$72.6K 1.07% 37
2017
Q2 		$944K Buy
6,590
+800
+14% +$108K 1.07% 36
2017
Q1 		$725K Buy
5,790
+275
+5% +$31.9K 0.87% 45
2016
Q4 		$621K Sell
5,515
-19,953
-78% -$2.31M 0.8% 47
2016
Q3 		$2.82M Sell
25,468
-2,960
-10% -$355K 0.91% 22
2016
Q2 		$3.11M Buy
28,428
+9,407
+49% +$936K 1.07% 22
2016
Q1 		$1.8M Sell
19,021
-66,272
-78% -$5.59M 0.58% 59
2015
Q4 		$7.7M Buy
85,293
+78,139
+1,092% +$6.63M 3.06% 1
2015
Q3 		$664K Sell
7,154
-35,614
-83% -$3.14M 0.25% 116
2015
Q2 		$2.81M Buy
+42,768
New +$2.84M 1.02% 20

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Coe Capital Management's ABMD Position: Q2 2021 in Review

Coe Capital Management increased its Abiomed Inc (ABMD) stake by 0.9% in Q2 2021, buying an estimated $7.06K and bringing the position to 2,587 shares worth $807K. The position accounts for 0.76% of the portfolio, ranked #38.

Coe Capital Management first reported a position in ABMD in Q2 2015 and has held it in 25 quarters since. The position peaked at $7.7M in Q4 2015. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Coe Capital Management held 2,587 shares of Abiomed Inc worth $807K as of Q2 2021.
  • Coe Capital Management bought 23 Abiomed Inc shares in Q2 2021, an estimated $7.06K.
  • Abiomed Inc made up 0.76% of Coe Capital Management's portfolio in Q2 2021, its #38 holding.
  • Coe Capital Management first reported a position in Abiomed Inc in Q2 2015 and has held it in 25 quarters since.
  • Coe Capital Management's Abiomed Inc position peaked at $7.7M in Q4 2015.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Coe Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.